https://www.selleckchem.com/pr....oducts/linderalacton
There are few reports of COVID-19 in pediatric patients with rheumatic diseases. This study describes the clinical presentation and outcomes of COVID-19 in this population. We analyzed a single-center case series of pediatric patients with rheumatic diseases and laboratory-confirmed COVID-19. Demographic, baseline and COVID-19 associated clinical features were compared between ambulatory and hospitalized patients using univariate analysis. Fifty-five cases were identified 45 (81.8%) in the ambulatory group and 10 (18.2%) hospital
Like
Comment
Share
